PSO THERA

Manufacturer
PSODEX USA INC | BERKO ILAC VE KIMYA SANAYI ANONIM SIRKETI-SULTANBEYLI SUBESI
Effective date
2023-12-21
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-06-01 00:06:10

Label at a glance#

ProductPSO THERA Scalp Psoriasis
Active ingredientTAZAROTENE
Label structure17 sections

Storage and handling

Other information : Store at controlled room temperature 59-86°F

Label contents#

Full prescribing information#

PSO-THERA Scalp Psoriasis Shampoo

DESCRIPTION SECTION

Psoriasis is a chronic disease that often comes and goes.

The main goal of treatment is to manage symptoms

PSODEX Pso-Thera Scalp Psoriasis Shampoo offers a soothing formula that helps block the recurrence of Scalp Psoriasis symptoms with the help of TAZAROTENE

PREVENTS:
Excessive skin cell growth


RELIEVES:
Itching, inflammation, and roughness


CONTROLS:
Flaking, scaling, and excessive sebum secretion


HELPS BLOCK:
Recurrence of Scalp Psoriasis symptoms

PSO-THERA Scalp Psoriasis Shampoo

INACTIVE INGREDIENT SECTION

Inactive Ingredients:

Allantoin, Bisabolol, Caprylyl Glycol, Citric Acid, Colloidal Oatmeal, Decyl Glucoside, Disodium Cocoamphodiacete, Disodium EDTA, Distilled Water, Glycerin, Guar Hydroxypropyltrimonium Chloride, Mentha Piperita Leaf Extract, Phenoxyethanol, Polyquaternium-10, Salicylic Acid, Xanthan Gum

PSO-THERA Scalp Psoriasis Shampoo

INDICATIONS & USAGE SECTION

Use:

Treats Scalp Psoriasis

PSO-THERA Scalp Psoriasis Shampoo

INFORMATION FOR OWNERS/CAREGIVERS SECTION

DISTRIBUTED BY: Psodex USA Inc.

9898 Bissonnet St Ste 625 Houston, TX 77036

1-844 4PSODEX www.psodexusa.com

MANUFACTURED FOR

Yesim Derma Laboratories

PSO-THERA Scalp Psoriasis Shampoo

INSTRUCTIONS FOR USE SECTION

Directions:

Apply shampoo to wet hair and scalp, foam, and massage onto scalp.
Leave it on for 2-3 minutes.
Rinse thoroughly.
For best results, at least use twice a week or as directed by a doctor.

PSO-THERA Scalp Psoriasis Shampoo

OTC - ACTIVE INGREDIENT SECTION

Active ingredient:

Tazarotene 0.05%

PSO-THERA Scalp Psoriasis Shampoo

OTC - ASK DOCTOR SECTION

Ask a doctor before use if: Condition covers a
large area of the body.

​PSO-THERA Scalp Psoriasis Shampoo

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children: If swallowed, get medical help or contact a Poison Control Center right away.

​PSO-THERA Scalp Psoriasis Shampoo

OTC - STOP USE SECTION

Stop use and ask a doctor if: Condition worsens or does not improve after regular use of this product as directed.

​PSO-THERA Scalp Psoriasis Shampoo

OTC - DO NOT USE SECTION

Do not use:

On children under 12 years of age, pregnant or breastfeeding women, individuals with eczema or retinoid hypersensitivity
On damaged or irritated skin not caused by acne or psoriasis
For prolonged periods of time without consulting a doctor

​PSO-THERA Scalp Psoriasis Shampoo

OTC - PURPOSE SECTION

Purpose:

Controls symptoms of Scalp Psoriasis

​PSO-THERA Scalp Psoriasis Shampoo

OTC - QUESTIONS SECTION

Questions or Comments: 1 844 4PSODEX | info@psodexusa.com

​PSO-THERA Scalp Psoriasis Shampoo

OTC - WHEN USING SECTION

When using this product:

Avoid contact with eyes, mouth, and other mucous membranes. If contact occurs, rinse thoroughly with water. If irritation or sensitivity develops, discontinue use and consult a doctor. Use caution in exposing skin to sunlight after applying this product. It may increase your tendency to sunburn up to 6 hours after application.

​PSO-THERA Scalp Psoriasis Shampoo

STORAGE AND HANDLING SECTION

Other information : Store at controlled room temperature 59-86°F

​PSO-THERA Scalp Psoriasis Shampoo

WARNINGS SECTION

Warnings: For external use only

PSO-THERA Scalp Psoriasis Shampoo

DOSAGE & ADMINISTRATION SECTION

Tazarotene 0.05%

PSO-THERA Scalp Psoriasis Shampoo

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PackagePackage

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2672343tazarotene 0.05 % Medicated ShampooPSN2
2672343tazarotene 0.5 MG/ML Medicated ShampooSCD2
2672343tazarotene 0.05 % Medicated ShampooSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
TAZAROTENE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
a107c35c-2cb4-4734-a92b-e9ed5cfc34d6Product name220260220
5993ea1b-833d-fa4b-caad-a0d477537538Product name520250305
c24b0f4e-b27e-8e2b-a129-1b5a6d72c459Product name220231128
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
18da2240-e326-4d63-90cd-d6bb15f662a0Product name120200604
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
a32b252c-8cd2-cc4a-c64c-4b9d3916df9eProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
73503-011-00PSO THERAScalp Psoriasis1000 mL in 1 BOTTLESHAMPOO10002

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
73503-011PSO THERA SCALP PSORIASIS (TAZARATONE) SHAMPOO [PSODEX USA INC]21 package rows20240101_031592a4-6252-bb22-e063-6394a90a2441.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 19 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
73503-01173503-011-00

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
0d0e86c3-de38-3e1f-e063-6394a90a5b13031592a4-6252-bb22-e063-6394a90a24412023-12-21WarningsExact identifier
spl id: 0d0e86c3-de38-3e1f-e063-6394a90a5b13
spl set id: 031592a4-6252-bb22-e063-6394a90a2441

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.